Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 4,787 $ 42,848
Accounts receivable, net 34,353 0
Current assets - discontinued operations 0 602,386
Total current assets 39,140 645,234
Intangible assets, net 0 271,870
Long-term assets - discontinued operations 0 8,838,224
TOTAL ASSETS 39,140 9,755,328
Current liabilities:    
Accounts payable and accrued liabilities 579,216 843,554
Notes payable - related party 300,000 0
Notes payable 920,000 300,000
Current liabilities - discontinued operations 425,604 453,352
Total current liabilities 2,224,820 1,596,906
Long-term liabilities - discontinued operations 0 23,943
TOTAL LIABILITIES 2,224,820 1,620,849
Commitments and contingencies
Stockholders' (deficit) equity:    
Preferred stock, $.001 par value; 5,000,000 shares authorized at September 30, 2018 and December 31, 2017; no shares issued and outstanding 0 0
Common stock, $.001 par value; 45,000,000 shares authorized at September 30, 2018 and December 31, 2017; 16,200,369 and 12,662,974 shares issued and outstanding, respectively 16,200 12,663
Additional paid-in capital 28,188,474 24,646,229
Accumulated deficit (30,390,354) (16,524,413)
TOTAL STOCKHOLDERS' (DEFICIT) EQUITY (2,185,680) 8,134,479
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 39,140 $ 9,755,328